{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:18:39Z","timestamp":1777486719797,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1750-9378-9-26","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T09:18:03Z","timestamp":1407835083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer"],"prefix":"10.1186","volume":"9","author":[{"given":"Rafal S","family":"Sobota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Ramogola-Masire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola M","family":"Zetola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"issue":"12","key":"498_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Canc J Int Canc. 2010, 127 (12): 2893-2917.","journal-title":"Int J Canc J Int Canc"},{"issue":"1","key":"498_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189 (1): 12-19.","journal-title":"J Pathol"},{"issue":"8","key":"498_CR3","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","volume":"70","author":"M Schiffman","year":"2010","unstructured":"Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M: A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70 (8): 3159-3169.","journal-title":"Cancer Res"},{"issue":"5\u20136","key":"498_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000214919","volume":"12","author":"RD Burk","year":"2009","unstructured":"Burk RD, Chen Z, Van Doorslaer K: Human papillomaviruses: genetic basis of carcinogenicity. Publ Health Genomics. 2009, 12 (5\u20136): 281-290.","journal-title":"Publ Health Genomics"},{"issue":"1","key":"498_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM de Villiers","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology. 2004, 324 (1): 17-27.","journal-title":"Virology"},{"issue":"1","key":"498_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","volume":"401","author":"HU Bernard","year":"2010","unstructured":"Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010, 401 (1): 70-79.","journal-title":"Virology"},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/10635150390235520","volume":"52","author":"S Guindon","year":"2003","unstructured":"Guindon S, Gascuel O: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003, 52: 696-704.","journal-title":"Syst Biol"},{"key":"498_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2013.05.012","volume":"445","author":"KV Doorslaer","year":"2013","unstructured":"Doorslaer KV: Evolution of the Papillomaviridae. Virology. 2013, 445: 11-20.","journal-title":"Virology"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-9378-4-8","volume":"4","author":"M Schiffman","year":"2009","unstructured":"Schiffman M, Clifford G, Buonaguro FM: Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agents Canc. 2009, 4: 8-","journal-title":"Infect Agents Canc"},{"issue":"Suppl 3","key":"498_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.vaccine.2006.05.026","volume":"24","author":"G Clifford","year":"2006","unstructured":"Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL: Chapter 3: HPV type distribution in women with and without cervical neoplastic diseases. Vaccine. 2006, 24 (Suppl 3): 26-34.","journal-title":"Vaccine"},{"issue":"5","key":"498_CR11","first-page":"607","volume":"45","author":"E Barr","year":"2007","unstructured":"Barr E, Tamms G: Quadrivalent human papillomavirus vaccine. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2007, 45 (5): 607-609.","journal-title":"Clin Infect Dis: Offic Publ Infect Dis Soc Am"},{"issue":"3","key":"498_CR12","doi-asserted-by":"publisher","first-page":"e90625","DOI":"10.1371\/journal.pone.0090625","volume":"9","author":"A Jaquet","year":"2014","unstructured":"Jaquet A, Horo A, Ekouevi DK, Toure B, Coffie PA, Effi B, Lenaud S, Messou E, Minga A, Sasco AJ: Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in C\u00f4te d'Ivoire. West Africa PLoS One. 2014, 9 (3): e90625-","journal-title":"West Africa PLoS One"},{"issue":"3","key":"498_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/00003495-200868030-00007","volume":"68","author":"SJ Keam","year":"2008","unstructured":"Keam SJ, Harper DM: Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]. Drugs. 2008, 68 (3): 359-372.","journal-title":"Drugs"},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1479-5876-8-105","volume":"8","author":"L Mariani","year":"2010","unstructured":"Mariani L, Venuti A: HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future. J Transl Med. 2010, 8: 105-","journal-title":"J Transl Med"},{"issue":"10","key":"498_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","volume":"12","author":"T Malagon","year":"2012","unstructured":"Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M: Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012, 12 (10): 781-789.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"498_CR16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2165\/00003495-200666090-00008","volume":"66","author":"MA Siddiqui","year":"2006","unstructured":"Siddiqui MA, Perry CM: Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs. 2006, 66 (9): 1263-1271. discussion 1272-1263","journal-title":"Drugs"},{"issue":"1","key":"498_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/1471-2407-14-451","volume":"14","author":"M Camargo","year":"2014","unstructured":"Camargo M, Soto-De Leon SC, Munoz M, Sanchez R, Pe\u0148a-Herrera D, Pineda-Pe\u0148a AC, Sussmann O, Paez C, Perez-Prados A, Patarroyo ME: Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia. BMC Cancer. 2014, 14 (1): 451-","journal-title":"BMC Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-9-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:50:53Z","timestamp":1548129053000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-9-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-9-26","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,12]]},"assertion":[{"value":"4 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}